2011

04 24, 2014
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) approved the cobas® HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The appr...
> more
 

Our goal is to partner with news reporters and provide relevant information that is of interest to various audiences. Media with questions related to Roche or its products may contact us at: 

 +1-317-521-2000

 

  email

 

 Roche US News


November 19, 2013
Indiana Biosciences Research Institute Hits $50 Million Start-up Funding Goal
The Indiana Biosciences Research Institute announced today that it has reached the first $50 million funding milestone, fueling continued momentum in ...
> more

November 19, 2013
Roche to sponsor clinical chemistry fellowship at UC San Diego School of Medicine
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Diagnostics division will provide an educational grant that will be used to sponsor a Clin...
> more

November 13, 2013
Roche to showcase automated molecular and tissue diagnostics technology, next-gen sequencing at AMP 2013 Annual Meeting
Roche (SIX: RO, ROG; OTCQX: RHHBY) will exhibit a diverse portfolio of molecular technology for clinical diagnostic applications and life science rese...
> more

July 30, 2013
Roche unveils intelligent automation management solution at 2013 Clinical Lab Expo
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced plans today at the AACC 2013 Clinical Lab Expo for the U.S. introduction of the cobas 8100 automated work...
> more

 Roche Global News

Retrieving Data